Short answer
CME Group (CME) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results covered quarter ended June 30, 2026; press release dated July 22, 2026.
CME Group 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results covered quarter ended June 30, 2026; press release dated July 22, 2026
- Exhibit 99.1 contains CME Group’s financial results and detailed operating performance
- Non-GAAP revenue, expenses, operating income, net income and EPS included alongside GAAP measures
- Non-GAAP reconciliations support comparability with prior reports but may include recurring adjustments
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $1.7B and net income $1.0B; adjusted EPS $2.99 versus $2.96 in Q2 2025
- ADV 29.8M contracts, third-highest quarterly level, while clearing and transaction fees reached $1.4B
- Market data revenue rose 20% to record $238M, strengthening recurring, higher-margin revenue diversification
- $95B in daily margin efficiencies supports client retention and CME’s competitive clearing proposition
- Returned capital through $468M dividends and $695M share repurchases; cash $2.3B versus debt $3.4B at June 30, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CME Group 8-K filings
Get the next CME 8-K as it lands
Follow CME for push alerts, or ask the research agent what this filing means.